ReviewFrontiers in bioengineering and biotechnology2021
Advances in Biosensors for Continuous Glucose Monitoring Towards Wearables.
Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 3 syntheses or guidelines pooled it, 163 citations in OpenAlex.
- Artificial intelligence in diabetes management: transformative potential, challenges, and opportunities in healthcare.Hormones (Athens, Greece) · 2025Pooled it
- The Effectiveness of Wearable Devices Using Artificial Intelligence for Blood Glucose Level Forecasting or Prediction: Systematic Review.Journal of medical Internet research · 2023Pooled it
- Recent Implementations of Hydrogel-Based Microbial Electrochemical Technologies (METs) in Sensing Applications.Sensors (Basel, Switzerland) · 2023Pooled it
- Biophotonics point-of-care diagnostics in low-resource settings: a South African perspective.Journal of biomedical optics · 2026Review
- Quasi-spherical gold nanoparticles as peroxidase-like nanozymes for broad-range colorimetric detection of hydrogen peroxide and glucose.RSC advances · 2026Article
- Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions.MedComm · 2026Review
- Nanomaterial-Enabled Fiber-Optic SPR Biosensor for Continuous and Noninvasive Body Fluid Monitoring:Progress and Prospects.Nanomaterials (Basel, Switzerland) · 2026Review
- The Convergence of Polymer Science and Predictive Modeling for Noninvasive Glucose Monitoring.Pharmaceutics · 2025Review
- Article
- Nanostructured Materials in Glucose Biosensing: From Fundamentals to Smart Healthcare Applications.Biosensors · 2025Review
- Nanomedicine-Driven Modulation of the Gut-Brain Axis: Innovative Approaches to Managing Chronic Inflammation in Alzheimer's and Parkinson's Disease.International journal of molecular sciences · 2025Review
- 3D Printing Assisted Wearable and Implantable Biosensors.Biosensors · 2025Review
- Glucose monitoring intelligent tracking system for remote glycemic assessment in diabetic dogs: a novel approach.BMC veterinary research · 2025Article
- Advancements in Wearable and Implantable BioMEMS Devices: Transforming Healthcare Through Technology.Micromachines · 2025Review
- Metal Nanocomposites as Biosensors for Biological Fluids Analysis.Materials (Basel, Switzerland) · 2025Review
- A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring.Nature biomedical engineering · 2025Review
- Recent Advances in Enzymatic Biofuel Cells to Power Up Wearable and Implantable Biosensors.Biosensors · 2025Review
- A Compact 2-D photonic crystal biomedical sensor for enhanced glucose concentration detection in urine.Scientific reports · 2025Article
- Non-invasive blood glucose monitoring using PPG signals with various deep learning models and implementation using TinyML.Scientific reports · 2025Article
- Revolutionary self-powered transducing mechanism for long-lasting and stable glucose monitoring: achieving selective and sensitive bacterial endospore germination in microengineered paper-based platforms.Microsystems & nanoengineering · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Continuous glucose monitors (CGMs) for the non-invasive monitoring of diabetes are constantly being developed and improved. Although there are multiple biosensing platforms for monitoring glucose available on the market, there is still a strong need to enhance their precision, repeatability, wearability, and accessibility to end-users. Biosensing technologies are being increasingly explored that use different bodily fluids such as sweat and tear fluid, etc., that can be calibrated to and therefore used to measure blood glucose concentrations accurately. To improve the wearability of these devices, exploring different fluids as testing mediums is essential and opens the door to various implants and wearables that in turn have the potential to be less inhibiting to the wearer. Recent developments have surfaced in the form of contact lenses or mouthguards for instance. Challenges still present themselves in the form of sensitivity, especially at very high or low glucose concentrations, which is critical for a diabetic person to monitor. This review summarises advances in wearable glucose biosensors over the past 5 years, comparing the different types as well as the fluid they use to detect glucose, including the CGMs currently available on the market. Perspectives on the development of wearables for glucose biosensing are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.